| BGEVX | CEUAX | BGEVX / CEUAX | |
| Total Expense Ratio | 0.42 | 0.86 | 49% |
| Annual Report Gross Expense Ratio | 0.42 | 0.86 | 49% |
| Fund Existence | 14 years | 25 years | - |
| Gain YTD | 3.967 | 5.423 | 73% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 500000000 | 250 | 200,000,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.91B | 140B | 2% |
| Annual Yield % from dividends | 0.21 | 2.52 | 8% |
| Returns for 1 year | -5.66 | 2.04 | -278% |
| Returns for 3 years | 27.36 | 27.28 | 100% |
| Returns for 5 years | -31.58 | -4.19 | 753% |
| Returns for 10 years | 39.85 | 51.84 | 77% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FACGX | 185.57 | 1.03 | +0.56% |
| Fidelity Advisor Growth Opps C | |||
| HIBCX | 52.18 | 0.13 | +0.25% |
| Hartford Capital Appreciation HLS IB | |||
| RYVFX | 11.69 | -0.06 | -0.51% |
| Royce Small-Cap Value Service | |||
| HFCSX | 34.31 | -0.19 | -0.55% |
| Hennessy Focus Investor | |||
| FBTDX | 170.40 | -3.12 | -1.80% |
| Franklin Biotechnology Discovery C | |||